SS Innovations International aces Race beating Global Giants in Surgical Robotics

In a First to India, Maker of Surgical Robot SSiMantra, brings ultimate Laurel

New Delhi: Indian Medtech company SS Innovations’ SSiMantra, the best in class only ‘Made in India’ surgical robot, was already giving all giants in the surgical robotics domain run for their money by its trail blazing accomplishments, the latest being intercontinental cardiac tele- surgery in which surgeon and the patient were 20, 000 kilometer between India and Guyana. There are many, you name it. But bagging the ultimate laurel of outstanding company award at the Surgical Robotics Technology (SRT) Industry Awards 2026 is out of the world indeed.

This first to India, the outstanding Company Award, puts it in the league of global giants in diverse fields. This award is one of the most prestigious awards in the world. The trophy is so extraordinary that it will cry hoarse from the roof of the world that SSiMantra is best in class surgical robot in the world. SS Innovations International will be spared of the pain of telling to the world that it is best in class.   

It was an Eureka moment for In a India’s medical technology sector and ambitious goal of ‘Make in India’ SS Innovations International being honored with the Outstanding Company award at the Surgical Robotics Technology (SRT) Industry Awards 2026, one of the world’s most prestigious recognitions dedicated exclusively to surgical robotics and the first Indian company to receive so.. The achievement marks a significant milestone for the company, which was selected from an exceptional field of globally renowned surgical robotics innovators and medical technology leaders, including Intuitive, Medtronic, Johnson & Johnson MedTech, Distalmotion, Meril, MicroPort, THINK Surgical, FUTEK and Precision IO Group, reaffirming its emergence as a leading force in the global surgical robotics landscape.

Now in its fourth edition, the Surgical Robotics Technology (SRT) Industry Awards are regarded as one of the world’s most respected honors celebrating excellence in surgical robotics. Organised by Surgical Robotics Technology (SRT), the leading global news and intelligence platform dedicated exclusively to the surgical robotics ecosystem, in partnership with QNX, the awards recognize organizations, technologies and industry leaders driving transformative advancements in robotic assisted surgery. The annual awards celebrate excellence in innovation, clinical impact, technological leadership and commercial achievement across the global surgical robotics landscape.

The 2026 winners represent some of the most influential organizations and leaders shaping the future of robotic surgery. Steve Bell received the Industry Leadership award for his outstanding contribution to MedTech and surgical robotics. Microbot Medical was recognised as the Innovative Start-upSentante won the Groundbreaking Technology award for the Sentante Robotic System. Moon Surgical received the Software Innovation award for Maestro Insights, while Dr. Brian Cohen of Cohen Orthopedic was honoured as the Outstanding Healthcare Provider. Together, the winners reflect the highest standards of innovation and excellence across the global surgical robotics ecosystem, with SS Innovations International earning the coveted Outstanding Company title.

Commenting on the recognition, Dr. Sudhir SrivastavaFounder Chairman and CEO of SS Innovations International, said, “Winning the Outstanding Company award at the SRT Industry Awards is a proud milestone for SS Innovations International and for India. This recognition validates our commitment to developing world class surgical robotic technologies that are innovative, accessible and affordable. It inspires us to continue advancing our mission of transforming surgical care through cutting edge technology and expanding access to robotic surgery across the world.”

Over the past few years, SS Innovations International has rapidly established itself as one of the fastest growing innovators in surgical robotics through its flagship SSI Mantra Surgical Robotic System. Developed in India with a vision to democratise robotic surgery, the system has enabled advanced minimally invasive procedures while expanding access to robotic surgery through affordability, technological innovation and pioneering advancements in telesurgery. The company continues to strengthen its global presence through growing clinical adoption, regulatory milestones and continued investment in next generation surgical technologies.

The Outstanding Company recognition marks another defining milestone in SS Innovations International‘s journey and reinforces India’s growing stature as a global hub for advanced medical technology innovation. It reflects the confidence of the international surgical robotics community in the company’s technological capabilities, vision and commitment to shaping the future of surgery.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre